|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
Key: Meeting
Showing releases 526-550 out of 952. << < 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 > >>
Public Release: 18-Apr-2012
 Biology of ReproductionLactating tsetse flies models for lactating mammals? An unprecedented study of intra-uterine lactation in the tsetse fly reveals that an enzyme found in the fly's milk functions similarly in mammals, making the tsetse a potential model for lipid metabolism during mammalian lactation. Better yet, reduced levels of this enzyme led to poor health in offspring, leading the authors to suggest that targeting it could help decrease the tsetse population in Africa and so reduce the incidence of sleeping sickness. 
National Institutes of Health, Ambrose Monell Foundation Awards
Contact: Joshua B. Benoit
Public Release: 17-Apr-2012
2012 International Microbicides ConferenceNew findings reported by Microbicide Trials Network researchers at HIV prevention meeting Women who use hormonal contraception are at no greater risk of HIV, according to a retrospective review of data from an HIV prevention trial conducted more than three years ago, the latest set of conflicting results on this perplexing issue. Yet tests of stored samples from the same trial have also identified a possible biomarker for identifying women who may be more susceptible to infection. Results of both studies were reported at Microbicides 2012.
National Institutes of Health
Contact: Lisa Rossi
Public Release: 17-Apr-2012
PLOS MedicineBiostatistics research could improve resource use in AIDS treatment in poor nations A major problem that has slowed progress toward universal access to life-saving antiretroviral therapy to treat AIDS in developing nations has been limited availability of laboratories and medical staff to conduct blood tests of immune system CD-4 levels that indicate when to start ART. UMass Amherst Biostatistician Andrea Foulkes, with colleagues at the Wistar Institute and elsewhere, propose a tool for prioritizing laboratory-based CD-4 cell count testing by linking cell counts to other patient data.
National Institutes of Health, Philadelphia Foundation, Wistar Institute
Contact: Janet Lathrop
Public Release: 16-Apr-2012
2012 International Microbicides ConferenceNew hope in HIV prevention research: International Microbicide Conference focuses on what works and next steps Researchers, activists and funders are meeting this week in Sydney to discuss the state of HIV prevention research. The biennial International Microbicides Conference, which was opened on Sunday evening by the Honorable Tanya Plibersek MP, Australian Minster of Health, is taking place amid renewed optimism about development and delivery of new HIV prevention options with the potential for ending the AIDS epidemic, including anti-retroviral based microbicides and pre-exposure prophylaxis (PrEP). Contact: Annette Larkin
Public Release: 12-Apr-2012
New study identifies promising, achievable solutions to Nigeria's childhood mortality crisis A study released today by the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health has identified the most feasible and impactful solutions for Nigeria's immunization program that could offer the best hope yet for scaling up vaccine access to the nation's most rural areas and taking aim at the country's precipitous number of child deaths. Contact: Julie Younkin
Public Release: 12-Apr-2012
AstraZeneca and DNDi to collaborate on drug screening for neglected tropical diseases AstraZeneca and the Drugs for Neglected Diseases initiative today announce an agreement to collaborate on drug-compound screening for leishmaniasis, Chagas disease, and sleeping sickness, three neglected tropical diseases which together affect nearly 10 million people worldwide. Novel drug candidates to emerge from this collaboration will bolster the drug development pipeline for new medicines urgently needed by millions of patients. Contact: Oliver Yun
Public Release: 10-Apr-2012
Washington's Life Sciences Discovery Fund awards commercialization grants The Life Sciences Discovery Fund today announced nearly $450,000 in awards to three Washington non-profit organizations to foster commercial translation of new health and health-care products. Contact: Cathyryne Manner
Public Release: 10-Apr-2012
Canadian Medical Association JournalWaging war against rotavirus Canada should show leadership in supporting adoption of the rotavirus vaccination in developing countries, but it must also ensure that all Canadian infants are vaccinated against the virus, states an editorial in CMAJ (Canadian Medical Association Journal). Contact: Kim Barnhardt
Public Release: 10-Apr-2012
Canadian Medical Association JournalCanada should play a role in addressing the global cancer epidemic Cancer is a growing health concern in low- and middle-income countries, and there is an opportunity for Canada to make a significant contribution to help tackle the disease, states an analysis in CMAJ (Canadian Medical Association Journal). Contact: Kim Barnhardt
Public Release: 9-Apr-2012
PLOS ONEBlack flies may have a purpose after all Black flies drink blood and spread disease such as river blindness -- creating misery with their presence. A University of Georgia study, however, proves that the pesky insects can be useful. Contact: Don Champagne
Public Release: 9-Apr-2012
New poll shows New York voters support global health research but unsure where it is conducted New York voters recognize the importance of global health research and are concerned about the United States' ability to compete globally, according to a new poll commissioned by Research!America, yet an overwhelming majority (93 percent) of those polled don't know where global health research is conducted in their own state. Contact: Angie Antonopoulos
Public Release: 8-Apr-2012
Nature GeneticsExperts identify critical genes mutated in stomach cancer An international team of scientists, led by researchers from the Duke-NUS Graduate Medical School (Duke-NUS) in Singapore and National Cancer Center of Singapore, has identified hundreds of novel genes that are mutated in stomach cancer, the second-most lethal cancer worldwide.
National Medical Research Council, Singapore Gastric Cancer Consortium, Cancer Sciences Institute of Singapore, Duke-NUS Graduate Medical School, Genome Institute of Singapore, Lee Foundation
Contact: Mary Jane Gore
Public Release: 6-Apr-2012
PLOS BiologyResearchers use game to change how scientists study disease outbreaks An international team of scientists--including researchers who teach an annual clinic at the African Institute for Mathematical Sciences in Muizenberg, South Africa -- is helping epidemiologists improve the mathematical models they use to study outbreaks of diseases like cholera, AIDS and malaria.
National Science Foundation
Contact: Cheryl Dybas
Public Release: 5-Apr-2012
ScienceEmergence of artemisinin-resistance on Thai-Myanmar border raises specter of untreatable malaria Evidence that the most deadly species of malaria parasite, Plasmodium falciparum, is becoming resistant to the front line treatment for malaria on the border of Thailand and Myanmar is reported in the Lancet today. This increases concern that resistance could now spread to India and then Africa as resistance to other antimalarial drugs has done before. Eliminating malaria might then prove impossible. Contact: Craig Brierley
Public Release: 5-Apr-2012
New studies highlight setbacks and advances in global malaria fight Emergence of resistance to the drug artemisinin in western Thailand has created a critical point in global efforts to control and eliminate malaria worldwide, according to a new study by researchers at the Texas Biomedical Research Institute and in Thailand. A second study by the same group identifies a major region of the malaria parasite genome associated with artemisinin resistance, raising hope that there will soon be effective molecular markers for monitoring the spread of resistance.
National Institutes of Health, Wellcome Trust
Contact: Joseph Carey
Public Release: 4-Apr-2012
NIH awards $20 million over 5 years to train next generation of global health researchers To help foster the next generation of global health scientists, Fogarty International Center and its partners at the National Institutes of Health are building a network of US academic institutions to provide early-career physicians, veterinarians, dentists and scientists with a significant mentored research experience in a developing country. About $20.3 million will be awarded over the next five years to support 400 early-career scientists on year-long research fellowships in 27 countries.
Fogarty International Center, National Institutes of Health
Contact: Ann Puderbaugh
Public Release: 3-Apr-2012
Optometry and Vision ScienceDon't send your recycled glasses to developing countries You might feel good sending your old reading glasses to a developing country. But a recent international study, led by the International Centre for Eyecare Education, a collaborating partner in the Vision CRC in Sydney, suggests it is far better to give $10 for an eye examination and a new pair of glasses if you want to help someone in desperate need, and it is far better for building capacity in these communities. Contact: Niall Byrne
Public Release: 3-Apr-2012
Proceedings of the National Academy of SciencesScripps Research Institute scientists find promising vaccine targets on hepatitis C virus A team led by scientists at the Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus in cell culture and animal models.
National Institutes of Health
Contact: Mika Ono
Public Release: 2-Apr-2012
Clemson scientist receives NIH grant to continue study of deadly tropical disease Clemson University researcher James Morris received a $360,079 competitive renewal grant from the National Institutes of Health to continue his study of Trypanosoma brucei, the single-celled parasite that causes African sleeping sickness.
National Institues of Health
Contact: James Morris
Public Release: 2-Apr-2012
PLOS MedicineCombination drug treatment can cut malaria by 30 percent Malaria infections among infants can be cut by up to 30 percent when antimalarial drugs are given intermittently over a 12-month period, a three-year clinical trial in Papua New Guinea has shown.
Bill and Melinda Gates Foundation
Contact: Liz Williams
Public Release: 29-Mar-2012
American Journal of Human GeneticsBreast cancer risk gene discovery fast tracked by new technology An international team of researchers led by the University of Melbourne, Australia, has used new technology to fast track the discovery of a breast cancer risk gene and could assist in the discovery of other cancer genes. Contact: Rebecca Scott
Public Release: 29-Mar-2012
PLOS PathogensDengue virus turns on mosquito genes that make them hungrier Researchers at the Johns Hopkins Bloomberg School of Public Health have, for the first time, shown that infection with dengue virus turns on mosquito genes that makes them hungrier and better feeders, and therefore possibly more likely to spread the disease to humans. Specifically, they found that dengue virus infection of the mosquito's salivary gland triggered a response that involved genes of the insect's immune system, feeding behavior and the mosquito's ability to sense odors.
NIH/National Institute for Allergy and Infectious Diseases
Contact: Tim Parsons
Public Release: 28-Mar-2012
New England Journal of MedicineResearchers identify genetic basis of tropical foot and leg lymphedema Writing in the March 29, 2012 New England Journal of Medicine, an international team that includes researchers from the National Human Genome Research Institute describes the genetic link to podoconiosis. The condition affects four million people in at least 10 countries and causes a painful inflammation of the lower extremities that, over time, leads to foot disfigurement.
National Institutes of Health, Wellcome Trust
Contact: Raymond MacDougall
Public Release: 28-Mar-2012
New England Journal of MedicineGenome study confirms immune system link to disfiguring leg swelling Genetic variants in a region of the genome linked to our immune response have been linked to increased risk of podoconiosis, a disfiguring and disabling leg swelling caused by an abnormal reaction to the minerals found in soil. An estimated four million people worldwide suffer from the condition.
Wellcome Trust, Association of Physicians of Great Britain
Contact: Craig Brierley
Public Release: 27-Mar-2012
HepatologyOver 20 million individuals infected with hepatitis E in Asia and Africa New research funded by the World Health Organization estimates that 20.1 million individuals were infected with hepatitis E virus genotypes one and two across nine world regions in 2005. According to findings available in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, there were 3.4 million symptomatic cases, 70,000 deaths, and 3,000 stillbirths from HEV that year in countries throughout Asia and Africa.
World Health Organization
Contact: Dawn Peters
Showing releases 526-550 out of 952. << < 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 > >>
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||
|
|
 |
|
